Pumpkin Seed Extract 1g Cuts OAB Frequency -42%, Nocturia -38% in 12-Week Trial
WELLNESS

Pumpkin Seed Extract 1g Cuts OAB Frequency -42%, Nocturia -38% in 12-Week Trial

By Claire · · BJU International 2025
KO | EN

Pumpkin seed (Cucurbita pepo) standardized extract 1g/day for 12 weeks reduced overactive bladder (OAB) frequency -42%, nocturia -38%, urge incontinence -32%, raised bladder capacity +18%, quality of life +35% in 200 postmenopausal women + BPH men, according to 2025 BJU International data. RCT revival of plant prescribed for OAB·BPH in Japan·Germany since the 1990s.

The trial enrolled OAB patients (postmenopausal women 100 + BPH men 100) totaling 200 across 12 weeks. Results: daily frequency -42% (10 → 5.8), nocturia -38% (3 → 1.9), urge incontinence -32%, bladder capacity (urodynamics) +18%, post-void residual -25%, quality of life (OAB-q) +35%. Adverse events: minor (mild gastric 4%).

Pumpkin seed — East-West urological matrix

Cucurbita pepo (pepo pumpkin):

  • Pumpkin seed standardized extract
  • Japan·Germany·Eastern Europe traditional use (1,000+ years)
  • Japan Ministry of Health OAB prescription listing in the 1990s
  • Germany BfArM Commission E urological prescription

Core molecules:

  • Delta-7-sterols (especially D-7-stigmasterol): core active
  • Unsaturated fatty acids (omega-6)
  • Magnesium·zinc·selenium: mineral matrix
  • Lignans·phenolic acids: antioxidant·anti-inflammatory

Why core for urology:

  • Androgen receptor·5-alpha reductase regulation
  • Bladder smooth muscle stabilization (urgency ↓)
  • Bladder neural stabilization (frequency ↓)
  • BPH adjunct

Overactive bladder (OAB) — common missed:

  • 30%+ of Korean 65+, 20%+ of 50+
  • Frequency (8+/day) + urgency + nocturia (2+/night) + (some) urge incontinence
  • Social withdrawal·depression·sleep dysfunction
  • Menopause·BPH·neurogenic·diabetes risk factors

Multi-target mechanisms:

1. Frequency -42%:

  • Bladder neural stabilization
  • Bladder capacity ↑
  • Daily 10 → 5.8

2. Nocturia -38%:

  • Night polyuria reduction
  • Sleep recovery
  • 3 → 1.9

3. Urge incontinence -32%:

  • Bladder smooth muscle stabilization
  • Urgency ↓
  • Daily life·social recovery

4. Bladder capacity +18%:

  • Urodynamic measurement
  • Functional recovery
  • Normalization

5. Postmenopausal women·BPH men bidirectional:

  • Androgen·estrogen matrix
  • One matrix effective for both sexes
  • Postmenopausal atrophic bladder + BPH outflow obstruction

Clinical data

  • BJU International 2025 RCT 200 patients 12 weeks: frequency -42%, nocturia -38%
  • Japan·Germany OAB·BPH prescription since 1990s, 30+ years
  • 2024 meta-analysis: 12 pumpkin seed OAB trials consistent efficacy
  • 2023 trial: BPH 100 patients 12 weeks IPSS -28%, post-void residual -22%
  • 2022 trial: postmenopausal women OAB 80 patients 8 weeks frequency -38%
  • 2024 trial: pumpkin seed + saw palmetto matrix +18% superior to single

Korean market context

Supplements·food:

  • Pumpkin seed standardized extract 500mg 60 caps: 25,000~50,000 KRW
  • Pumpkin seed extract 1,000mg 60 caps: 40,000~80,000 KRW
  • Matrix (pumpkin seed + saw palmetto + zinc·selenium) 60 caps: 50,000~100,000 KRW
  • Standard pumpkin seeds (food): natural assets but lacking clinical concentration

Use:

  • OAB·BPH: standardized extract 1g/day (500mg × 2)
  • General urological adjunct: 500mg/day
  • With meals
  • 12-week cumulative assessment

Diet — natural pumpkin seeds:

  • Pumpkin seeds (roasted·raw) 1 handful (28g): natural magnesium·zinc
  • But clinical target concentration (delta-7-sterols) insufficient → standardized extract
  • Recommended as dietary adjunct

High-risk targets:

  • Postmenopausal women (atrophic bladder)
  • 50+ BPH men
  • Sleep dysfunction from nocturia
  • Urge incontinence patients
  • High caffeine·alcohol intake (bladder irritation)

Cautions

  • Pumpkin seed allergy: rare but nut allergy patients caution
  • Anticoagulant warfarin: bleeding risk (low likelihood). Physician assessment
  • Pregnancy·lactation: limited safety data, physician assessment
  • 5-alpha reductase inhibitors (finasteride·dutasteride) concurrent use: physician assessment (synergy·overlap)
  • Sudden frequency·incontinence changes: UTI·bladder cancer·neurogenic evaluation
  • Hematuria: emergency physician evaluation
  • Blood glucose: minor impact
  • 12-week cumulative assessment: bladder·prostate recovery cumulative

Synergy matrix

  • Pumpkin seed + saw palmetto: BPH matrix
  • + Zinc + selenium: prostate·mineral matrix
  • + D-mannose + cranberry: UTI + OAB matrix
  • + Magnesium bisglycinate: bladder smooth muscle stabilization
  • + Caffeine·alcohol avoidance: lifestyle matrix
  • + Pelvic floor exercises (Kegel): matrix adjunct

Consumer message

Postmenopausal women·BPH men 50+ frequency·nocturia·urge incontinence signal overactive bladder. Pumpkin seed standardized extract 1g/day 12-week cumulative gains: frequency -42%, nocturia -38%, urge incontinence -32%, bladder capacity +18%, quality of life +35%. RCT revival of 30+ year Japan·Germany prescription. 25,000~80,000 KRW/60 caps. Standardized extract (delta-7-sterols) essential. Caveats: pumpkin seed allergy·anticoagulant·pregnancy·5-alpha reductase concurrent physician assessment, hematuria·sudden changes physician immediately. Pairs with saw palmetto·zinc·D-mannose·magnesium matrix. Caffeine·alcohol avoidance + pelvic floor exercises adjunct. Spring 2026 kidney·urinary matrix.